TEVA logo

TEVA Operating Expenses

Latest reported$2.00B
TEVA Quarterly Operating Expenses ($0.00 → $2.00B)
High-resolution chart · PNG

TEVA operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
117,895,000
118,059,000
124,721,000
105,911,000
124,057,000
81,585,000
159,457,000
76,800,000
76,100,000
71,900,000
129,700,000
77,600,000
65,100,000
62,500,000
-943,100,000
0
0
0
-824,500,000
0
0
0
-552,500,000
0
0
0
-481,000,000
0
0
0
-414,000,000
0
0
0
-350,700,000
0
0
0
-275,000,000
0
0
0
-288,700,000
0
0
0
-236,900,000
0
0
0
-188,600,000
0
0
0
0
0
0
0
0
-79,300,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.